Ellen Geerdens
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
Papers in
-
- Acute Myeloid Leukemia Research 5
- Chronic Myeloid Leukemia Treatments 5
- Genetics 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Co-authors
- Jan CoolsSofie DemeyerPeter VandenbergheValentina GianfeliciAnne UyttebroeckCharles E. de BockKim De KeersmaeckerSandrine Degryse
- Journals
- Blood (5 papers)Haematologica (4 papers)Leukemia (3 papers)Cancer Cell (1 paper)PLoS Genetics (1 paper)
- Partner nations
- BelgiumNetherlandsFrance
In The Last Decade
Ellen Geerdens
17 papers receiving 962 citations
Peers
Comparison fields: 5 of 62
- Hematology 315
- Genetics 134
- Public Health, Environmental and Occupational Health 337
- Cancer Research 146
- Pathology and Forensic Medicine 152
Countries citing papers authored by Ellen Geerdens
This map shows the geographic impact of Ellen Geerdens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Geerdens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Geerdens more than expected).
Fields of papers citing papers by Ellen Geerdens
This network shows the impact of papers produced by Ellen Geerdens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Geerdens. The network helps show where Ellen Geerdens may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ellen Geerdens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 33 | |
| 2 | 2018 | 70 | |
| 3 | 2018 | 63 | |
| 4 | 2018 | 42 | |
| 5 | 2017 | 59 | |
| 6 | 2017 | 26 | |
| 7 | 2017 | 23 | |
| 8 | 2017 | 30 | |
| 9 | 2016 | 40 | |
| 10 | HEDGEHOG PATHWAY ACTIVATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PREDICTS RESPONSE TO SMO AND GLI1 INHIBITORS | 2016 | 1 |
| 11 | 2015 | 113 | |
| 12 | 2014 | 40 | |
| 13 | 2014 | 109 | |
| 14 | 2013 | 99 | |
| 15 | 2013 | 92 | |
| 16 | 2012 | 46 | |
| 17 | 2012 | 84 |
About Ellen Geerdens
Ellen Geerdens is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Cancer Research and Pathology and Forensic Medicine, having authored 17 papers that have together received 970 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), RNA modifications and cancer (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Hematology (315 citations), Genetics (134 citations), Public Health, Environmental and Occupational Health (337 citations), Cancer Research (146 citations) and Pathology and Forensic Medicine (152 citations). Ellen Geerdens has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Jan Cools, Sofie Demeyer, Peter Vandenberghe, Valentina Gianfelici, Anne Uyttebroeck, Charles E. de Bock, Kim De Keersmaecker, Sandrine Degryse, Jean Soulier and Olga Gielen. Their work appears in journals such as Blood, Haematologica, Leukemia, Cancer Cell and PLoS Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.